tirzepatide for heart failure with preserved ejection fraction and obesity Managing in Failure: Latest Evidence Knowledge Gaps | Current Treatment Options in Cardiovascular Medicine Tirzepatide Improves HFpEF Symptoms and

And thank you so much again for coming on today and sharing your knowledge

2026) found that, after twelve months on GLP-1 medications, there was a raised risk not only of telogen effluvium but also of androgenetic alopecia (a factor of 1.64)

Some days are worse than others

Most people who push through the three-month initial period report substantially easier tolerability at the same dose

These insights reveal whether your body naturally responds well to semaglutide, whether you'd benefit from tirzepatide or dual-compound therapy, and how aggressively to escalate dosing

They are approved only for type 2 diabetes and weight management within specialist services